Platelet Function Testing and Genotyping for Tailoring Treatment in Complex PCI Patients
Dual antiplatelet therapy (DAPT), comprising aspirin and a P2Y12 receptor inhibitor, is considered the cornerstone of treatment in patients who have undergone percutaneous coronary intervention (PCI). Patients with complex PCI (C-PCI) constitute a special PCI subpopulation, characterized by increase...
Saved in:
| Main Authors: | Athanasios Moulias, Angeliki Papageorgiou, Dimitrios Alexopoulos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-08-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articleindex/usc.2020.33 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of Endothelial Function in Patients with COVID-19 Using Peripheral Arterial Tonometry
by: Athanasios Moulias, et al.
Published: (2024-11-01) -
Perforations in Complex PCI
by: Thomas J. Ford, PhD, et al.
Published: (2025-01-01) -
Combination of Clopidogrel and Nicorandil Improves Post-Procedure Platelet Activation and Cardiac Function Impairment in Patients with Acute Coronary Syndrome Undergoing PCI
by: Zhenhao Cai, et al.
Published: (2025-05-01) -
Complex high-risk indicated PCI (CHIP-PCI): is it safe to let fellows-in-training perform it as primary operators?
by: Tim Kinnaird, et al.
Published: (2025-01-01) -
Prophylactic VA-ECMO During Complex High-Risk PCI
by: Chenliang Pan, MD, et al.
Published: (2025-09-01)